UNICYTE EV AG has a total of 34 patent applications. It decreased the IP activity by 75.0%. Its first patent ever was published in 2016. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are HEMISPHERX BIOPHARMA, ZOETIS W LLC and BESTEWIL HOLDING BV.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 10 | |
#2 | EPO (European Patent Office) | 9 | |
#3 | United States | 6 | |
#4 | China | 4 | |
#5 | Canada | 2 | |
#6 | Australia | 1 | |
#7 | Brazil | 1 | |
#8 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Chemical engineering |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Microorganisms | |
#3 | Therapeutic chemical compounds | |
#4 | Analysing materials | |
#5 | Measuring microorganism processes | |
#6 | Separation |
# | Name | Total Patents |
---|---|---|
#1 | Camussi Giovanni | 32 |
#2 | Brizzi Maria Felice | 15 |
#3 | Bussolati Benedetta | 12 |
#4 | Deregibus Maria Chiara | 8 |
#5 | Dimuccio Veronica | 6 |
#6 | Ranghino Andrea | 5 |
#7 | Lopatina Tatiana | 5 |
#8 | Figliolini Federico | 4 |
#9 | Tetta Ciro | 4 |
#10 | Cavallari Claudia | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020249567A1 | Extracellular vesicles from human liver stem cells (hlsc-evs) for reducing cellular senescence | |
WO2020188433A1 | Method for predicting proangiogenic potential of extracellular vesicles (evs) | |
EP3812769A1 | A method for in vitro diagnosis of renal glomerular disease or for monitoring the progression of renal glomerular disease | |
WO2020030561A1 | Extracellular vesicles loaded with an exogenous molecule | |
WO2019197442A1 | A combination of active ingredients for the treatment of tumor | |
CN111601890A | Pharmaceutical vector comprising miRNA for treating renal cancer | |
KR20190005209A | A pharmaceutical carrier containing miRNA for use in the treatment of fibrotic diseases caused by hyperglycemia | |
EP3443112A1 | Isolation of extracellular vesicles (evs) from biological fluid samples | |
EP3308795A1 | A composition of extracellular vesicles (evs) and medical uses thereof | |
EP3246703A1 | Method and kit for capturing extracellular vesicles (evs) on a solid surface |